바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

logo

메뉴

약물유발 치은비대증의 비외과적 치료

Abstract

keywords

참고문헌

1.

1. Kimball OP.:The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA 1939;112:1244- 1245.

2.

2. Rateitschak-Pl?ss EM., Hefti A., Lörtscher R., Thiel G.:Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;157:237-246.

3.

3. Lederman D., Lumerman H., Reuben S., Freedman PD.:Gingival hyperplasia associated with nifedipine therapy. Report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1984;57:620-622.

4.

4. Ramon Y., Behar S., Kishon Y., Engelberg IS.: Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5:195-204.

5.

5. Colvard MD., Bishop J., Weissman D., Gargiulo AV.:Cardizem induced gingival hyperplasia:a report of two cases. Periodontal Case Rep. 1986;8:67-8.

6.

6. Giustiniani S., Robustelli della Cuna F., Marieni M.:Hyperplastic gingivitis during diltiazem therapy. Int J Cardiol. 1987;15:247-9.

7.

7. Syrjänen SM., Syrjänen KJ.:Hyperplastic gingivitis in a child receiving sodium valproate treatment. Proc Finn Dent Soc. 1979;75:95-8.

8.

8. Behari M.:Gingival hyperplasia due to sodium valproate. J Neurol Neurosurg Psychiatry. 1991;54:279-80.

9.

9. Valsecchi R., Cainelli T.:Gingival hyperplasia induced by erythromycin. Acta Derm Venereol. 1992;72:157.

10.

10. Angelopoulos AP., Goaz PW.:Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol. 1972;34:898-906.

11.

11. Seymour RA., Smith DG., Rogers SR.:The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol. 1987;14:610-3.

12.

12. Barclay S., Thomason JM., Idle JR., Seymour RA.:The incidence and severity of nifedipineinduced gingival overgrowth. J Clin Periodontol. 1992;19:311-4.

13.

13. Addy V., McElnay JC., Eyre DG., Campbell N., D’ Arcy PF.:Risk factors in phenytoin-induced gingival hyperplasia. J Periodontol. 1983;54:373-7.

14.

14. Daley TD., Wysocki GP., Day C.:Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol. 1986;62:417-21.

15.

15. Seymour RA., Thomason JM., Ellis JS.:The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol. 1996;23:165-75.

16.

16. Camargo PM., Melnick PR., Pirih FQ., Lagos R., Takei HH.:Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontol 2000. 2001;27:131-8.

logo